Version 1
: Received: 27 December 2022 / Approved: 29 December 2022 / Online: 29 December 2022 (14:35:18 CET)
How to cite:
M. Alarifi, A.; Alshahrani, N.Z.; Sah, R. Are Saudi Healthcare Workers (HCW) Willing to Receive the Monkeypox Virus Vaccine?. Preprints2022, 2022120562. https://doi.org/10.20944/preprints202212.0562.v1
M. Alarifi, A.; Alshahrani, N.Z.; Sah, R. Are Saudi Healthcare Workers (HCW) Willing to Receive the Monkeypox Virus Vaccine?. Preprints 2022, 2022120562. https://doi.org/10.20944/preprints202212.0562.v1
M. Alarifi, A.; Alshahrani, N.Z.; Sah, R. Are Saudi Healthcare Workers (HCW) Willing to Receive the Monkeypox Virus Vaccine?. Preprints2022, 2022120562. https://doi.org/10.20944/preprints202212.0562.v1
APA Style
M. Alarifi, A., Alshahrani, N.Z., & Sah, R. (2022). Are Saudi Healthcare Workers (HCW) Willing to Receive the Monkeypox Virus Vaccine?. Preprints. https://doi.org/10.20944/preprints202212.0562.v1
Chicago/Turabian Style
M. Alarifi, A., Najim Z. Alshahrani and Ranjit Sah. 2022 "Are Saudi Healthcare Workers (HCW) Willing to Receive the Monkeypox Virus Vaccine?" Preprints. https://doi.org/10.20944/preprints202212.0562.v1
Abstract
Early experience with Covid-19 shows that vaccines can be the most effective way of preventing the spread of infection. However, vaccine hesitancy is among the most significant hurdles in preventing the spread of novel infections. Monkeypox (MPX) has already been declared a global health emergency by WHO. Thus, there is an urgent need to understand the MPX vaccine willingness in various population groups. In this cross-sectional study, an online survey was conducted among Saudi healthcare workers (HCWs) to understand the monkeypox vaccine willingness in healthcare workers in Saudi Arabia. Saudi has already confirmed multiple MPX cases, and thus it is essential to initiate timely protective measures, including vaccination. The study had 743 respondents. The study found that among Saudi HCWs, 52.7% were willing to receive the MPX vaccine. The study found that sociodemographic factors had a small impact on vaccine willingness. However, early experience with vaccination had a significant impact. Thus, more than 70% who had influenza or COVID-19 vaccine were willing to receive the MPX vaccine. Some of the most significant concerns influencing vaccine acceptability were the safety and efficacy of the vaccine. Hence, it is strongly recommended to focus on disseminating information regarding the safety and efficacy of the MPX vaccine.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
